Early Lopinavir/ritonavir does not reduce mortality in COVID-19 patients: Results of a large multicenter study

被引：6
|
作者：
Lora-Tamayo, Jaime [1 ]
Maestro, Guillermo [1 ]
Lalueza, Antonio [1 ]
Rubio-Rivas, Manuel [2 ]
Villarreal Paul, Gracia [3 ]
Arnalich Fernandez, Francisco [4 ]
Beato Perez, Jose Luis [5 ]
Vargas Nunez, Juan Antonio [6 ]
Llorente Barrio, Monica [7 ]
Lumbreras Bermejo, Carlos [1 ]
机构：
[1] 12 Octubre Univ Hosp, Res Inst Hosp 12 Octubre I 12 Inst, Internal Med Dept, Madrid, Spain
[2] Bellvitge Univ Hosp IDIBELL, Internal Med Dept, Lhospitalet De Llobregat, Barcelona, Spain
[3] Gregorio Maranon Univ Hosp, Internal Med Dept, Madrid, Spain
[4] La Paz Univ Hosp, Internal Med Dept, Madrid, Spain
[5] Albacete Univ Hosp Complex, Internal Med Dept, Albacete, Spain
[6] Puerta Hierro Univ Hosp, Internal Med Dept, Majadahonda, Madrid, Spain
[7] Miguel Servet Hosp, Internal Med Dept, Zaragoza, Spain
来源：
JOURNAL OF INFECTION | 2021年 / 82卷 / 06期
关键词：
D O I：
10.1016/j.jinf.2021.02.011
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：293 / 298
页数：6
相关论文
共 50 条
  • [41] Effect of hydroxychloroquine, azithromycin and lopinavir/ritonavir on the QT corrected interval in patients with COVID-19
    Echarte-Morales, Julio
    Minguito-Carazo, Carlos
    del Castillo-Garcia, Samuel
    Borrego-Rodriguez, Javier
    Rodriguez-Santamarta, Miguel
    Sanchez-Munoz, Enrique
    Bergel-Garcia, Ruben
    Gonzalez-Maniega, Clea
    Prieto-Gonzalez, Silvia
    Menendez-Suarez, Paula
    Tundidor-Sanz, Elena
    Benito-Gonzalez, Tomas
    Fernandez-Vazquez, Felipe
    JOURNAL OF ELECTROCARDIOLOGY, 2021, 64 : 30 - 35
  • [42] Acute Kidney Injury Associated With Lopinavir/Ritonavir Combined Therapy in Patients With COVID-19
    Binois, Yannick
    Hachad, Hafsah
    Salem, Joe-Elie
    Charpentier, Julien
    Lebrun-Vignes, Benedicte
    Pene, Frederic
    Cariou, Alain
    Chiche, Jean-Daniel
    Mira, Jean-Paul
    Nguyen, Lee S.
    KIDNEY INTERNATIONAL REPORTS, 2020, 5 (10): : 1787 - 1790
  • [43] Prediction of lopinavir/ritonavir effectiveness in COVID-19 patients: a recall of basic pharmacology concepts
    Cattaneo, Dario
    Corbellino, Mario
    Gervasoni, Cristina
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (05) : 791 - 792
  • [44] Therapy with lopinavir/ritonavir and hydroxychloroquine is associated with acute kidney injury in COVID-19 patients
    Schneider, Johanna
    Jaenigen, Bernd
    Wagner, Dirk
    Rieg, Siegbert
    Hornuss, Daniel
    Biever, Paul M.
    Kern, Winfried V.
    Walz, Gerd
    PLOS ONE, 2021, 16 (05):
  • [45] Safety and effectiveness concerns of lopinavir/ritonavir in COVID-19 affected patients: a retrospective series
    Lepage, Marc-Antoine
    Rozza, Nicholas
    Kremer, Richard
    Grunbaum, Ami
    CLINICAL TOXICOLOGY, 2021, 59 (07) : 644 - 647
  • [46] Hydroxychloroquine treatment does not reduce COVID-19 mortality; underdosing to the wrong patients?
    Ayerbe, Luis
    Risco-Risco, Carlos
    Nunez-Gil, Ivan
    Perez-Pinar, Maria
    Ayis, Salma
    LANCET RHEUMATOLOGY, 2021, 3 (03): : E172 - E172
  • [47] Lopinavir-ritonavir versus darunavir-norvir for hospitalized COVID-19 patients
    Paroczai, Dora
    Bikov, Andras
    Blidaru, Andreea
    Bobu, Emanuel
    Cerbu, Bianca
    Marincu, Iosif
    Mihaicuta, Stefan
    Frent, Stefan
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [48] Efficacy and Safety of Atazanavir/Ritonavir Versus Lopinavir/Ritonavir in Hospitalized COVID-19 Patients: A Randomized Clinical Trial
    Siami, Zeinab
    Dehghan, Danial
    Khavandegar, Armin
    Lak, Mehran
    Bakhtiyari, Mahmood
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2022, 24 (05)
  • [49] Comparing the effectiveness of Atazanavir/Ritonavir/Dolutegravir/Hydroxychloroquine and Lopinavir/Ritonavir/Hydroxychloroquine treatment regimens in COVID-19 patients
    Kalantari, Saeed
    Fard, Soheil R.
    Maleki, Donya
    Taher, Mahshid T.
    Yassin, Zeynab
    Alimohamadi, Yousef
    Minaeian, Sara
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (12) : 6557 - 6565
  • [50] Hydroxychloroquine versus lopinavir/ritonavir in severe COVID-19 patients Results from a real-life patient cohort
    Karolyi, Mario
    Pawelka, Erich
    Mader, Theresa
    Omid, Sara
    Kelani, Hasan
    Ely, Sarah
    Jilma, Bernd
    Baumgartner, Sebastian
    Laferl, Hermann
    Ott, Clemens
    Traugott, Marianna
    Turner, Michael
    Seitz, Tamara
    Wenisch, Christoph
    Zoufaly, Alexander
    WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (7-8) : 284 - 291
12345